rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Immuron Limited - American Depositary Shares

IMRN · Nasdaq

Health CareBiotechnologyJust dropped out

IMRN stood above a rising 150-day average in 12 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 8.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
5 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders5-2 on the quarter
New · exited1 · 3
Reported value$61K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CITADEL ADVISORS LLCadded · filed 14 Aug 202643,123$46K+29,319+212.4%
RHUMBLINE ADVISERSunchanged · filed 12 Aug 20267,367$7,80800.0%
BNP PARIBAS FINANCIAL MARKETSadded · filed 13 Aug 20265,200$5,512+600+13.0%
MORGAN STANLEYreduced · filed 13 Aug 20261,700$1,802-28,874−94.4%
UBS Group AGnew · filed 13 Aug 2026363$385+363
31 Mar 2023 – 30 Jun 2026
158Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2026 · to 30 Jun 202638.0%

Analyst forecasts

No analyst forecasts yet.